Begin main content

Eculizumab

Last Updated: January 7, 2013
Result type: Reports
Project Number: SR0304
Product Line: Common Drug Review

Generic Name: Eculizumab

Brand Name: Soliris

Manufacturer: Alexion Pharma Canada

Indications: Hemolytic Uremic Syndrome, Atypical

Submission Type: Pre-NOC

Project Status: Complete

Date Recommendation Issued: July 18, 2013

Recommendation Type: Do not list